Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.
Identifieur interne : 000182 ( Main/Exploration ); précédent : 000181; suivant : 000183Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.
Auteurs : Shoko Tsukube [Oman] ; Yukio Ikeda ; Takashi Kadowaki ; Masato OdawaraSource :
- Diabetes therapy : research, treatment and education of diabetes and related disorders [ 1869-6953 ] ; 2015.
Abstract
This study aimed to assess treatment satisfaction and self-reported health status in insulin-naïve patients with type 2 diabetes mellitus (T2DM) who started insulin glargine basal-supported oral therapy (BOT) with glycated hemoglobin (HbA1c) value of ≥6.5%, using data from Add-on Lantus(®) to Oral Hypoglycemic Agents 2 (ALOHA2) study, a 24-week single-arm, observational study of Japanese patients with T2DM, conducted as drug use surveillance in Japan.
DOI: 10.1007/s13300-015-0111-5
PubMed: 26040914
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000077
- to stream PubMed, to step Curation: 000077
- to stream PubMed, to step Checkpoint: 000088
- to stream Ncbi, to step Merge: 000D59
- to stream Ncbi, to step Curation: 000D59
- to stream Ncbi, to step Checkpoint: 000D59
- to stream Main, to step Merge: 000179
- to stream Main, to step Curation: 000182
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.</title><author><name sortKey="Tsukube, Shoko" sort="Tsukube, Shoko" uniqKey="Tsukube S" first="Shoko" last="Tsukube">Shoko Tsukube</name><affiliation wicri:level="1"><nlm:affiliation>Sanofi K.K., Tokyo Opera City Tower, 3-20-2 Nishi-shinjyuku, Shinjyuku-ku, Tokyo, 163-1488, Japan, DiabetesMedical.Sanofi@sanofi.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Sanofi K.K., Tokyo Opera City Tower, 3-20-2 Nishi-shinjyuku, Shinjyuku-ku, Tokyo, 163-1488, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Ikeda, Yukio" sort="Ikeda, Yukio" uniqKey="Ikeda Y" first="Yukio" last="Ikeda">Yukio Ikeda</name></author><author><name sortKey="Kadowaki, Takashi" sort="Kadowaki, Takashi" uniqKey="Kadowaki T" first="Takashi" last="Kadowaki">Takashi Kadowaki</name></author><author><name sortKey="Odawara, Masato" sort="Odawara, Masato" uniqKey="Odawara M" first="Masato" last="Odawara">Masato Odawara</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="doi">10.1007/s13300-015-0111-5</idno><idno type="RBID">pubmed:26040914</idno><idno type="pmid">26040914</idno><idno type="wicri:Area/PubMed/Corpus">000077</idno><idno type="wicri:Area/PubMed/Curation">000077</idno><idno type="wicri:Area/PubMed/Checkpoint">000088</idno><idno type="wicri:Area/Ncbi/Merge">000D59</idno><idno type="wicri:Area/Ncbi/Curation">000D59</idno><idno type="wicri:Area/Ncbi/Checkpoint">000D59</idno><idno type="wicri:doubleKey">1869-6953:2015:Tsukube S:improved:treatment:satisfaction</idno><idno type="wicri:Area/Main/Merge">000179</idno><idno type="wicri:Area/Main/Curation">000182</idno><idno type="wicri:Area/Main/Exploration">000182</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.</title><author><name sortKey="Tsukube, Shoko" sort="Tsukube, Shoko" uniqKey="Tsukube S" first="Shoko" last="Tsukube">Shoko Tsukube</name><affiliation wicri:level="1"><nlm:affiliation>Sanofi K.K., Tokyo Opera City Tower, 3-20-2 Nishi-shinjyuku, Shinjyuku-ku, Tokyo, 163-1488, Japan, DiabetesMedical.Sanofi@sanofi.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Sanofi K.K., Tokyo Opera City Tower, 3-20-2 Nishi-shinjyuku, Shinjyuku-ku, Tokyo, 163-1488, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Ikeda, Yukio" sort="Ikeda, Yukio" uniqKey="Ikeda Y" first="Yukio" last="Ikeda">Yukio Ikeda</name></author><author><name sortKey="Kadowaki, Takashi" sort="Kadowaki, Takashi" uniqKey="Kadowaki T" first="Takashi" last="Kadowaki">Takashi Kadowaki</name></author><author><name sortKey="Odawara, Masato" sort="Odawara, Masato" uniqKey="Odawara M" first="Masato" last="Odawara">Masato Odawara</name></author></analytic><series><title level="j">Diabetes therapy : research, treatment and education of diabetes and related disorders</title><idno type="ISSN">1869-6953</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study aimed to assess treatment satisfaction and self-reported health status in insulin-naïve patients with type 2 diabetes mellitus (T2DM) who started insulin glargine basal-supported oral therapy (BOT) with glycated hemoglobin (HbA1c) value of ≥6.5%, using data from Add-on Lantus(®) to Oral Hypoglycemic Agents 2 (ALOHA2) study, a 24-week single-arm, observational study of Japanese patients with T2DM, conducted as drug use surveillance in Japan.</div></front></TEI><affiliations><list><country><li>Oman</li></country></list><tree><noCountry><name sortKey="Ikeda, Yukio" sort="Ikeda, Yukio" uniqKey="Ikeda Y" first="Yukio" last="Ikeda">Yukio Ikeda</name><name sortKey="Kadowaki, Takashi" sort="Kadowaki, Takashi" uniqKey="Kadowaki T" first="Takashi" last="Kadowaki">Takashi Kadowaki</name><name sortKey="Odawara, Masato" sort="Odawara, Masato" uniqKey="Odawara M" first="Masato" last="Odawara">Masato Odawara</name></noCountry><country name="Oman"><noRegion><name sortKey="Tsukube, Shoko" sort="Tsukube, Shoko" uniqKey="Tsukube S" first="Shoko" last="Tsukube">Shoko Tsukube</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000182 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000182 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= OperaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26040914
|texte= Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26040914" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a OperaV1
| This area was generated with Dilib version V0.6.21. |  |